Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Werewolf Therapeutics stock
Learn how to easily invest in Werewolf Therapeutics stock.
Werewolf Therapeutics Inc is a biotechnology business based in the US. Werewolf Therapeutics shares (HOWL) are listed on the NASDAQ and all prices are listed in US Dollars. Werewolf Therapeutics employs 47 staff and has a trailing 12-month revenue of around $4.1 million.
How to buy shares in Werewolf Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HOWL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Werewolf Therapeutics stock price (NASDAQ: HOWL)Use our graph to track the performance of HOWL stocks over time.
Werewolf Therapeutics shares at a glance
|Latest market close||$4.83|
|52-week range||$3.42 - $18.22|
|50-day moving average||$5.63|
|200-day moving average||$6.35|
|Wall St. target price||$16.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$5.65|
Buy Werewolf Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Werewolf Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Werewolf Therapeutics price performance over time
|1 week (2022-09-23)||-3.78%|
|1 month (2022-09-01)||-20.17%|
|3 months (2022-07-01)||16.67%|
|6 months (2022-04-01)||7.33%|
|1 year (2021-10-01)||-72.00%|
|2 years (2020-09-27)||N/A|
|3 years (2019-09-27)||N/A|
|5 years (2017-09-27)||N/A|
Is Werewolf Therapeutics stock undervalued or overvalued?
Valuing Werewolf Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Werewolf Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Werewolf Therapeutics's P/E ratio
Werewolf Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Werewolf Therapeutics shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Werewolf Therapeutics's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.
Werewolf Therapeutics financials
|Revenue TTM||$4.1 million|
|Gross profit TTM||$0|
|Return on assets TTM||-21.2%|
|Return on equity TTM||-39.54%|
|Market capitalisation||$156.5 million|
TTM: trailing 12 months
Werewolf Therapeutics share dividends
We're not expecting Werewolf Therapeutics to pay a dividend over the next 12 months.
Werewolf Therapeutics overview
Werewolf Therapeutics, Inc. , a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Werewolf Therapeutics in the news
Werewolf Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1/1b Clinical Trial of WTX-124 for the Treatment of Patients with Selected Solid Tumors
Frequently asked questionsWhat percentage of Werewolf Therapeutics is owned by insiders or institutions?
Currently 19.206% of Werewolf Therapeutics shares are held by insiders and 73.867% by institutions. How many people work for Werewolf Therapeutics?
Latest data suggests 47 work at Werewolf Therapeutics. When does the fiscal year end for Werewolf Therapeutics?
Werewolf Therapeutics's fiscal year ends in December. Where is Werewolf Therapeutics based?
Werewolf Therapeutics's address is: 1030 Massachusetts Avenue, Cambridge, MA, United States, 02138 What is Werewolf Therapeutics's ISIN number?
Werewolf Therapeutics's international securities identification number is: US95075A1079
More guides on Finder
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Ask an Expert